Welcome to Takeda Patient Support

When you’re prescribed a Takeda treatment, Takeda Patient Support is here for you. Our dedicated specialists are ready to answer your questions and help get you the resources and tools you need. We can also:

Help you receive your treatment by getting you your medication when and where you need it
Connect you to co-pay or insurance help, and more

Learning about financial assistance options

Whether you have commercial insurance, have government insurance, or are uninsured, our support specialists can answer your questions and help you understand what financial assistance options may be available.

Have commercial insurance?

We can direct you to programs that may help you save on your treatment, if you’re eligible.

The Takeda Patient Support Co-Pay Assistance Program can cover up to 100% of your out-of-pocket co-pay costs, if you’re eligible.* To be eligible for this program, you must:

Be prescribed CUVITRU for a condition it’s approved to treat by the Food and Drug Administration (FDA). This is called an “approved indication.” Ask your healthcare provider if you’re not sure.

Have commercial insurance. This includes Health Insurance Marketplace plans.

Commercial insurance does not include Medicare, Medicaid, Veterans Affairs (VA), or other federal or state health plans.

Be enrolled in Takeda Patient Support.

The maximum co-pay assistance available annually is $20,000. If you reach the program maximum before the end of the period, Takeda will help you identify programs and resources that may provide you with additional assistance with access to your prescribed Takeda treatment. See below for terms and conditions.

*IMPORTANT NOTICE: The Takeda Patient Support Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-861-1750. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.

Are you enrolled in a government insurance program?

If you have government insurance, we are here to help answer questions about your coverage. This includes federal or state insurance such as Medicare, Medicare Advantage, or Medicaid.

Can’t afford your treatment?

If you do not have insurance or are experiencing a loss of or lapse in coverage, our support specialists may be able to connect you to programs that may help.

Woman on the phone while looking at her laptop.

Not enrolled?

You can join Takeda Patient Support in
a few simple steps at
TakedapatientSupport.com/enroll.

If English is not your preferred language, let us know.
We can assist you in a language of your choosing.

Visit TakedaPatientSupport.com

Contact a Rep

IMPORTANT SAFETY INFORMATION and serious warnings regarding blood clots

What is CUVITRU?

CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.

IMPORTANT SAFETY INFORMATION

What is the most important information that I should know about CUVITRU?

CUVITRU can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs, or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.

What is the most important information I need to know about CUVITRU?

CUVITRU can cause the following serious reactions:

Severe allergic reactions causing difficulty in breathing or skin rashes
Decreased kidney function or kidney failure
Blood clots in the heart, brain, lungs, or elsewhere in the body
Severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting
Dark colored urine, swelling, fatigue, or difficulty breathing

Who should not use CUVITRU?

Do not use CUVITRU if you:

Have had a severe allergic reaction to immune globulin or other blood products.
Have a condition called selective (or severe) immunoglobulin A (IgA) deficiency.

What should I avoid while taking CUVITRU?

CUVITRU can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your healthcare provider (HCP) that you take CUVITRU.
Tell your HCP if you are pregnant, or plan to become pregnant, or if you are nursing.

What are the possible or reasonably likely side effects of CUVITRU?

CUVITRU can cause serious side effects. If any of the following problems occur after starting CUVITRU, stop the infusion immediately and contact your HCP or call emergency services:

Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting or dizziness. These could be signs of a serious allergic reaction.
Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain.
Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem.
Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot.
Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem.
Chest pain or trouble breathing, or blue lips or extremities. These could be signs of a serious heart or lung problem.
Fever over 100°F. This could be sign of an infection.

The following one or more possible side effects may occur at the site of infusion. These generally go away within a few hours, and are less likely after the first few infusions.

Mild or moderate pain
Redness
Itching

The most common side effects that may occur are:

Headache
Nausea
Fatigue
Diarrhea
Vomiting

These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away.

For additional safety information, including Warning about Blood Clots, click for Information For Patients and discuss with your HCP.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.